CureVac NV (NAS:CVAC) Stock News, Headlines & Updates
CureVac NV Stock News from GuruFocus
- 1
Aug 15, 2024
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
ACCESSWIRE • 7:00am
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
ACCESSWIRE • 7:00am
CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board
ACCESSWIRE • 7:00am
Jul 11, 2024
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
ACCESSWIRE • 11:00am
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
ACCESSWIRE • 7:00am
Jul 03, 2024
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
ACCESSWIRE • 3:00am
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
ACCESSWIRE • 3:00am
Jun 25, 2024
CureVac Announces Voting Results of General Meeting
ACCESSWIRE • 7:00pm
May 28, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news